TGAオーストラリア供給不足情報(8月5日~8月11日)

Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
Coxiella burnetiiInjection50 microgram/mLCurrentLimited AvailabilityManufacturing9/08/2024
lisinopril dihydrateTablet, uncoated10.89 mgCurrentUnavailableManufacturing9/08/2024
duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing9/08/2024
sodium fluorideInjection, concentrated1 mg/mLResolvedAvailableManufacturing9/08/2024
OmalizumabInjection, solution150 mgCurrentEmergency Supply OnlyManufacturing9/08/2024
metformin hydrochlorideTablet, modified release1000 mgResolvedAvailableManufacturing9/08/2024
tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing9/08/2024
betahistine dihydrochlorideTablet, uncoated16 mgDiscontinuedUnavailableManufacturing9/08/2024
acarboseTablet50 mgAnticipatedAvailableManufacturing9/08/2024
mesalazineTablet, enteric coated800 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/08/2024
ezetimibeTablet, uncoated10 mgAnticipatedAvailableManufacturing9/08/2024
tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing9/08/2024
cinacalcet hydrochlorideTablet66.127 mgCurrentUnavailableManufacturing9/08/2024
dasatinibTablet, film coated50 mgCurrentUnavailableManufacturing9/08/2024
escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableCommercial Changes / Commercial viability9/08/2024
amlodipine besilate~olmesartan medoxomil~hydrochlorothiazideTablet, film coated6.95 mg~40 mg~25 mgCurrentUnavailableManufacturing9/08/2024
hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated12.5 mg~6.95 mg~40 mgCurrentLimited AvailabilityManufacturing9/08/2024
gefitinibTablet, film coated250 mgCurrentUnavailableProduct recall9/08/2024
lacosamideTablet, film coated50 mgResolvedAvailableManufacturing9/08/2024
atovaquone~proguanil hydrochlorideTablet, film coated62.5 mg~25 mgResolvedAvailableManufacturing9/08/2024
fluoxetine hydrochlorideCapsule, hard22.36 mgResolvedAvailableManufacturing9/08/2024
cabergolineTablet, uncoated2 mgAnticipatedAvailableManufacturing9/08/2024
desonideLotion.5 mg/gResolvedAvailableManufacturing9/08/2024
rizatriptan benzoateWafer14.53 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply9/08/2024
sodium oxidronateInjection, powder for3.15 mgResolvedAvailableManufacturing9/08/2024
methylphenidate hydrochlorideTablet, modified release18 mgAnticipatedAvailableManufacturing9/08/2024
zopicloneTablet, film coated7.5 mgCurrentUnavailableManufacturing9/08/2024
bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing8/08/2024
adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply8/08/2024
temozolomideCapsule, hard100 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues8/08/2024
tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability8/08/2024
tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing8/08/2024
tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing8/08/2024
adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgCurrentUnavailableManufacturing8/08/2024
teriflunomideTablet, film coated14 mgAnticipatedAvailableManufacturing8/08/2024
olanzapineTablet, uncoated7.5 mgResolvedAvailableManufacturing8/08/2024
BevacizumabInjection, concentrated25 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability8/08/2024
sitagliptin fumarateTablet, film coated64.249 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply8/08/2024
sodium valproateTablet, enteric coated500 mgAnticipatedAvailableManufacturing8/08/2024
fluorouracilInjection, solution50 mg/mLCurrentLimited AvailabilityManufacturing8/08/2024
clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand8/08/2024
nizatidineCapsule, hard300 mgAnticipatedAvailableManufacturing8/08/2024
roxithromycinTablet, film coated150 mgDiscontinuedUnavailableManufacturing8/08/2024
roxithromycinTablet, film coated300 mgDiscontinuedUnavailableManufacturing8/08/2024
framycetin sulfate~gramicidin~dexamethasoneEar Drops5 mg/mL~.05 mg/mL~.5 mg/mLCurrentUnavailableManufacturing7/08/2024
fluorouracilCream50 mg/gResolvedAvailableManufacturing7/08/2024
ketorolac trometamolInjection, solution30 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
risperidoneTablet.5 mgCurrentUnavailableManufacturing7/08/2024
risperidoneTablet1 mgCurrentUnavailableManufacturing7/08/2024
prochlorperazine maleateTablet5 mgResolvedAvailableManufacturing7/08/2024
tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentUnavailableManufacturing7/08/2024
fentanylDrug delivery system, transdermal10.2 mgDiscontinuedUnavailableCommercial Changes / Commercial viability7/08/2024
ondansetronTablet, orally disintegrating4 mgResolvedAvailableManufacturing7/08/2024
mycophenolate mofetilCapsule, hard250 mgDiscontinuedUnavailableManufacturing7/08/2024
sildenafil citrateTablet, film coated28.1 mgResolvedAvailableManufacturing7/08/2024
escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues7/08/2024
escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing7/08/2024
AbataceptInjection125.875 mgResolvedAvailableManufacturing7/08/2024
ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply7/08/2024
imatinib mesilateCapsule, hard119.47 mgResolvedAvailableManufacturing7/08/2024
clonidine hydrochlorideTablet100 microgramAnticipatedAvailableUnexpected increase in consumer demand7/08/2024
tadalafilTablet, film coated10 mgCurrentUnavailableManufacturing7/08/2024
tadalafilTablet, film coated20 mgCurrentUnavailableManufacturing7/08/2024
ephedrine hydrochlorideInjection, solution30 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
nebivolol hydrochlorideTablet5.45 mgResolvedAvailableManufacturing7/08/2024
tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing7/08/2024
hydrocortisone acetateEnema10 % w/wDiscontinuedUnavailableManufacturing7/08/2024
gramicidin~framycetin sulfate~dexamethasoneEar Drops.05 mg/mL~5 mg/mL~.5 mg/mLCurrentUnavailableManufacturing7/08/2024
rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing7/08/2024
eprosartan mesilateTablet, film coated735.8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
alprostadilInjection, powder for40 microgram/mLCurrentUnavailableManufacturing7/08/2024
sildenafil citrateTablet, film coated28.09 mgCurrentLimited AvailabilityUnexpected increase in consumer demand6/08/2024
ramiprilTablet, uncoated5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/08/2024
ramiprilTablet, uncoated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/08/2024
isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing6/08/2024
prochlorperazine maleateTablet5 mgResolvedAvailableManufacturing6/08/2024
pramipexole dihydrochloride monohydrateTablet.25 mgResolvedAvailableManufacturing6/08/2024
oseltamivir phosphateOral Liquid, powder for7.88 mg/mLCurrentEmergency Supply OnlyUnexpected increase in consumer demand6/08/2024
ropivacaine hydrochlorideInjection, solution400 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues6/08/2024
trandolaprilCapsule, hard2 mgCurrentLimited AvailabilityManufacturing6/08/2024
trandolaprilCapsule, hard4 mgCurrentLimited AvailabilityManufacturing6/08/2024
efmoroctocog alfaInjection, powder for250 IUCurrentUnavailableManufacturing6/08/2024
tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply6/08/2024
tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand6/08/2024
latanoprostEye Drops, solution.05 mg/mLResolvedAvailableManufacturing6/08/2024
bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLCurrentLimited AvailabilityManufacturing6/08/2024
nebivolol hydrochlorideTablet5.45 mgResolvedAvailableManufacturing6/08/2024
aciclovirInjection, solution25 mg/mLCurrentUnavailableManufacturing6/08/2024
iopromideInjection, solution768.86 mg/mLCurrentUnavailableUnexpected increase in consumer demand6/08/2024
timolol maleateEye Drops, solution6.84 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability6/08/2024
mianserin hydrochlorideTablet, film coated20 mgCurrentLimited AvailabilityManufacturing6/08/2024
estradiol~norethisterone acetateDrug delivery system, transdermal.512 mg~4.8 mgCurrentUnavailableManufacturing6/08/2024
alprostadilInjection, powder for20 microgram/mLCurrentUnavailableManufacturing6/08/2024
metformin hydrochlorideTablet, film coated500 mgCurrentUnavailableManufacturing6/08/2024
metformin hydrochlorideTablet, film coated1000 mgCurrentUnavailableManufacturing6/08/2024
zoledronic acid monohydrateInjection, solution5.33 mgResolvedAvailableManufacturing5/08/2024
olanzapine pamoate monohydrateInjection, powder for931 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
olanzapine pamoate monohydrateInjection, powder for690 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
olanzapine pamoate monohydrateInjection, powder for483 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
fentanylDrug delivery system, transdermal5.1 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/08/2024
fentanylDrug delivery system, transdermal2.55 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/08/2024
mirtazapineTablet, film coated45 mgAnticipatedAvailableManufacturing5/08/2024
timolol maleate~dorzolamide hydrochlorideEye Drops, solution6.83 mg/mL~22.26 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability5/08/2024
pramipexole dihydrochloride monohydrateTablet1 mgResolvedAvailableManufacturing5/08/2024
pramipexole dihydrochloride monohydrateTablet.125 mgResolvedAvailableManufacturing5/08/2024
ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing5/08/2024
rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrentLimited AvailabilityManufacturing5/08/2024
temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing5/08/2024
rosuvastatin calciumTablet, film coated10.42 mgResolvedAvailableManufacturing5/08/2024
cefuroxime axetilTablet, film coated300.715 mgCurrentLimited AvailabilityUnexpected increase in consumer demand5/08/2024
mupirocinOintment20 mg/gResolvedAvailableManufacturing5/08/2024
alfentanil hydrochlorideInjection, solution1.09 mgResolvedAvailableManufacturing5/08/2024
montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing5/08/2024
montelukast sodiumTablet, film coated10.4 mgCurrentLimited AvailabilityUnexpected increase in consumer demand5/08/2024
mycophenolate mofetilInjection, powder for500 mgCurrentUnavailableManufacturing5/08/2024
spironolactoneTablet, uncoated100 mgAnticipatedAvailableManufacturing5/08/2024
flecainide acetateTablet50 mgCurrentUnavailableManufacturing5/08/2024
indometacinCapsule, hard25 mgCurrentLimited AvailabilityManufacturing5/08/2024
temozolomideCapsule, hard5 mgAnticipatedAvailableManufacturing5/08/2024
raltitrexedInjection, powder for2 mgResolvedAvailableUnexpected increase in consumer demand5/08/2024
captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing5/08/2024
captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing5/08/2024
dorzolamide hydrochloride~timolol maleateEye Drops, solution22.26 mg/mL~6.83 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability5/08/2024
flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing5/08/2024
midazolamInjection, solution5 mg/mLCurrentUnavailableManufacturing5/08/2024
2024年8月12日
このページの先頭へ戻る